Shokei Kim
About
Shokei Kim is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology.
According to data from OpenAlex, Shokei Kim has authored 119 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 59 papers in Cardiology and Cardiovascular Medicine and 19 papers in Physiology. Recurrent topics in Shokei Kim's work include Renin-Angiotensin System Studies (40 papers), Receptor Mechanisms and Signaling (22 papers) and Cardiac Fibrosis and Remodeling (16 papers). Shokei Kim is often cited by papers focused on Renin-Angiotensin System Studies (40 papers), Receptor Mechanisms and Signaling (22 papers) and Cardiac Fibrosis and Remodeling (16 papers). Shokei Kim collaborates with scholars based in Japan, United States and Germany. Shokei Kim's co-authors include Hiroshi Iwao, Yasukatsu Izumi, Katsuyuki Miura, Tokihito Yukimura, Akinori Hamaguchi, Minoru Yoshiyama, Yumei Zhan, Kensuke Ohta, Shinya Yamanaka and Kazuhide Takeuchi and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Circulation Research.
In The Last Decade
Shokei Kim
118 papers receiving 5.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shokei Kim Japan | 44 | 2.6k | 2.6k | 1.1k | 915 | 737 | 119 | 5.9k | ||
| Hiroshi Iwao Japan | 48 | 3.2k 1.2× | 3.7k 1.4× | 1.2k 1.1× | 1.1k 1.2× | 857 1.2× | 249 | 8.2k | ||
| Toshihiro Ichiki Japan | 46 | 3.5k 1.3× | 3.4k 1.3× | 2.1k 1.9× | 1.1k 1.1× | 842 1.1× | 111 | 7.4k | ||
| George W. Booz United States | 41 | 2.6k 1.0× | 2.5k 1.0× | 878 0.8× | 613 0.7× | 597 0.8× | 148 | 6.1k | ||
| Wolfgang Siess Germany | 49 | 1.8k 0.7× | 3.1k 1.2× | 493 0.5× | 958 1.0× | 1.2k 1.6× | 157 | 8.0k | ||
| John R. Hagaman United States | 27 | 2.0k 0.8× | 2.1k 0.8× | 1.2k 1.1× | 704 0.8× | 614 0.8× | 47 | 5.1k | ||
| Mizuo Miyazaki Japan | 45 | 2.5k 1.0× | 2.1k 0.8× | 899 0.8× | 1.2k 1.3× | 804 1.1× | 242 | 6.6k | ||
| Andrew A. Protter United States | 43 | 1.4k 0.6× | 2.2k 0.9× | 489 0.5× | 941 1.0× | 939 1.3× | 80 | 6.0k | ||
| Christophe Heymes France | 40 | 2.9k 1.1× | 2.6k 1.0× | 1.3k 1.2× | 1.6k 1.8× | 985 1.3× | 86 | 6.2k | ||
| Edward P. Feener United States | 43 | 1.4k 0.5× | 2.8k 1.1× | 1.1k 1.0× | 1.3k 1.5× | 697 0.9× | 94 | 6.7k | ||
| Shokei Kim‐Mitsuyama Japan | 41 | 1.5k 0.6× | 1.7k 0.6× | 1.3k 1.2× | 1.0k 1.1× | 751 1.0× | 116 | 5.7k |
Countries citing papers authored by Shokei Kim
Since
Specialization
Citations
This map shows the geographic impact of Shokei Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shokei Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shokei Kim more than expected).
Fields of papers citing papers by Shokei Kim
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Shokei Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shokei Kim. The network helps show where Shokei Kim may publish in the future.
Co-authorship network of co-authors of Shokei Kim
This figure shows the co-authorship network connecting the top 25 collaborators of Shokei Kim. A scholar is included among the top collaborators of Shokei Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shokei Kim. Shokei Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Andoh, Akira, Shigeki Bamba, Sanae Fujino, et al.. (2004). Fibroblast Growth Factor-2 Stimulates Interleukin-6 Secretion in Human Pancreatic Periacinar Myofibroblasts. Pancreas. 29(4). 278–283.
2.
Fujii, Nobuharu, Marni D. Boppart, Scott D. Dufresne, et al.. (2004). Overexpression or ablation of JNK in skeletal muscle has no effect on glycogen synthase activity. American Journal of Physiology-Cell Physiology. 287(1). C200–C208.
3.
Kim, Shokei & Hiroshi Iwao. (2003). Stress and Vascular Responses: Mitogen-Activated Protein Kinases and Activator Protein-1 as Promising Therapeutic Targets of Vascular Remodeling. Journal of Pharmacological Sciences. 91(3). 177–181.
4.
Bamba, Shigeki, et al.. (2003). Regulation of IL-11 expression in intestinal myofibroblasts: role of c-Jun AP-1- and MAPK-dependent pathways. American Journal of Physiology-Gastrointestinal and Liver Physiology. 285(3). G529–G538.
5.
Ioroi, Takeshi, Motohiro Yamamori, Keiko Yagi, et al.. (2003). Dominant Negative c-Jun Inhibits Platelet-Derived Growth Factor-Directed Migration by Vascular Smooth Muscle Cells. Journal of Pharmacological Sciences. 91(2). 145–148.
6.
Miura, Katsuyuki, Mitsutaka Okumura, Shinya Yamanaka, Shokei Kim, & Hiroshi Iwao. (1999). No Participation of Adenosine A1 Receptor in Acute Nephrotoxicity by 4-Pentenoic Acid Administration in Dogs. The Japanese Journal of Pharmacology. 80(3). 223–228.
7.
Takemoto, Yasuhiko, Minoru Yoshiyama, Kazuhide Takeuchi, et al.. (1999). Increased JNK, AP-1 and NF-κB DNA Binding Activities in Isoproterenol-induced Cardiac Remodeling. Journal of Molecular and Cellular Cardiology. 31(11). 2017–2030.
8.
Yamanaka, Shinya, Xiaoying Zhang, Katsuyuki Miura, Shokei Kim, & Hiroshi Iwao. (1998). The Human Gene Encoding the Lectin-Type Oxidized LDL Receptor (OLR1) Is a Novel Member of the Natural Killer Gene Complex with a Unique Expression Profile. Genomics. 54(2). 191–199.
9.
Yoshizumi, Masanori, Shokei Kim, Shoji Kagami, et al.. (1998). Effect of endothelin‐1 (1‐31) on extracellular signal‐regulated kinase and proliferation of human coronary artery smooth muscle cells. British Journal of Pharmacology. 125(5). 1019–1027.
10.
Uchida, Junji, Katsuyuki Miura, Shinya Yamanaka, et al.. (1998). Renal Endothelin in FK506-Induced Nephrotoxicity in Spontaneously Hypertensive Rats. The Japanese Journal of Pharmacology. 76(1). 39–49.
11.
Miura, Katsuyuki, Takeshi Matsuura, Masahito Imanishi, et al.. (1996). Role of Platelet-Activating Factor and Prostanoids in Hemodynamic Changes in Rat Experimental Endotoxic Shock. The Japanese Journal of Pharmacology. 71(3). 247–253.
12.
Kim, Shokei, Akinori Hamaguchi, Yutaka Kato, et al.. (1996). Molecular effects of M17055, furosemide and thiazide on cardiac hypertrophy of spontaneously hypertensive rats.. Journal of Pharmacology and Experimental Therapeutics. 279(2). 983–990.
13.
Miura, Katsuyuki, Michiaki Okumura, Takeshi Matsuura, et al.. (1995). Attenuation of adrenomedullin‐induced renal vasodilatation by NG‐nitro L‐arginine but not glibenclamide. British Journal of Pharmacology. 115(6). 917–924.
14.
Yoshiyama, Minoru, Shokei Kim, Hiroyuki Yamagishi, et al.. (1994). Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury. American Heart Journal. 128(1). 1–6.
15.
Miura, Katsuyuki, Michiaki Okumura, Takeshi Matsuura, et al.. (1994). Effect of adrnomedullin on renal hemodynamics and functions in dogs. European Journal of Pharmacology. 263(1-2). 69–73.
16.
Kim, Shokei, Kensuke Ohta, Akinori Hamaguchi, et al.. (1994). AT1 receptor‐mediated stimulation by angiotensin II of rat aortic fibronectin gene expression in vivo. British Journal of Pharmacology. 113(3). 662–663.
17.
Yukimura, Tokihito, Yutaka Yamashita, Katsuyuki Miura, et al.. (1994). Renal vasodilating and diuretic actions of a selective endothelin ETB receptor agonist, IRL1620. European Journal of Pharmacology. 264(3). 399–405.
18.
Yamanaka, Shinya, Hiroshi Iwao, Tokihito Yukimura, Shokei Kim, & Katsuyuki Miura. (1993). Effect of the platelet‐activating factor antagonist, TCV‐309, and the cyclo‐oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock. British Journal of Pharmacology. 110(4). 1501–1507.
19.
Yamagishi, Hiroyuki, Shokei Kim, Toshio Nishikimi, Kazuhide Takeuchi, & Tadanao Takeda. (1993). Contribution of Cardiac Renin-Angiotensin System to Ventricular Remodelling in Myocardial-Infarcted Rats. Journal of Molecular and Cellular Cardiology. 25(11). 1369–1380.
20.
Kim, Shokei, et al.. (1991). Increased production of angiotensin II in the adrenal gland of stroke-prone spontaneously hypertensive rats with malignant hypertension. Biochemical and Biophysical Research Communications. 178(1). 151–157.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hiroshi Iwao Breakdown of academic impact, for papers by Toshihiro Ichiki Breakdown of academic impact, for papers by George W. Booz Breakdown of academic impact, for papers by Wolfgang Siess Breakdown of academic impact, for papers by John R. Hagaman Breakdown of academic impact, for papers by Mizuo Miyazaki Breakdown of academic impact, for papers by Andrew A. Protter Breakdown of academic impact, for papers by Christophe Heymes Breakdown of academic impact, for papers by Edward P. Feener Breakdown of academic impact, for papers by Shokei Kim‐Mitsuyama